(121 days)
SURGIN'S PRIZM BLADES ARE DESIGNATED AS REPLACEMENT BLADES FOR THE "BECTON DICKINSON BD - 3000 MICRO SURGICAL SYSTEM", TO BE USED FOR LAMELLAR RESECTION OF THE CORNEA
Not Found
This document is a 510(k) premarket notification letter from the FDA regarding the "PRIZM Keratome Blade." This type of document does not contain acceptance criteria or study results for device performance.
The letter confirms that the device is substantially equivalent to legally marketed predicate devices, allowing it to be marketed. It discusses regulatory classifications, general controls, and compliance requirements, but not specific performance metrics or studies.
Therefore, I cannot provide the requested information from this document. The sections you asked for, such as "A table of acceptance criteria and the reported device performance," "Sample sized used for the test set," "Number of experts used to establish the ground truth," etc., are details typically found in a device's submission dossier, which is not provided here.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes entwined around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus symbol. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Surgin, Inc. c/o Don Harr RA/OA Manager 14762 Bentley Circle Tustin, CA 92680
Re: K033182
Trade/Device Name: PRIZM Keratome Blade Regulation Number: 21 CFR 886.4370 Regulation Name: Keratome Regulatory Class: Class I Product Code: HNO Dated: December 16, 2003 Received: January 5, 2004
Dear Mr. Harr:
We have reviewed your Section 510(k) premarket notification of intent to market the device we have a rowed your and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the encreations of the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drag, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The r our may, merere, mans of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it rr your device is exactive (tional controls. Existing major regulations affecting your device can may or subject to back as of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial cquivalence determination does not mean I lease be actised that I Dr vistian that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must or uny redorm statutes the requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic ford in the quand cyerol provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
JAN 30 2004
{1}------------------------------------------------
Page 2 - Don Harr
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely vours,
Alegi Rosenthal
A. Ralph Rosenthal, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Surgin, Inc 14762 Bentley Circle Tustin, CA 92680 Tel: 714 832 6300
INDICATIONS FOR USE STATEMENT
K033182 510(k) Number (il known): Device Name: Purzu Barac Indications For Use: SUREN'S PM BUNDES AND DESIGNATI AS NEPLACEMENT Burdes For 7 The BESTON DICKINSON BD - 3000 MICH SHATUALE SYSTEM", To BE USED FOR CANECLAR PESEGENON OF THE CORNEA
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrance of CDRH, Office of Device Evaluation (ODE) | ||
|---|---|---|
| (Division Sign-Off) | ||
| Division of Ophthalmic Ear, Nose and Throat Devices | ||
| 510(k) Number | K033182 | |
| Prescription Use (Per 21 CFR 801.109) | OR | Over-The-Counter Use |
(Optional Format 1-2-96)
§ 886.4370 Keratome.
(a)
Identification. A keratome is an AC-powered or battery-powered device intended to shave tissue from sections of the cornea for a lamellar (partial thickness) transplant.(b)
Classification. Class I.